Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  


ASTRAZENECA PHARMA Plunges 5%; BSE HEALTHCARE Index Up 0.4%
Thu, 14 Nov 12:5

ASTRAZENECA PHARMA Plunges 5%; BSE HEALTHCARE Index Up 0.4%Image source: DNY59/www.istockphoto.com

ASTRAZENECA PHARMA share price has plunged 5% and is presently trading at Rs 6,754.2.

Meanwhile, the BSE HEALTHCARE index is at 42,622.8 (up 0.4%).

Among the top losers in the BSE HEALTHCARE index today are J.B.Chemicals (down 1.9%) and SUN PHARMA ADV. RES. (down 1.9%).

Jubilant Pharmova (up 3.5%) and GLAND PHARMA (up 2.9%) are among the top gainers today.

Over the last one year, ASTRAZENECA PHARMA has moved up from Rs 4,648.8 to Rs 6,754.2, registering a gain of Rs 2,105.4 (up 45.3%).

On the other hand, the BSE HEALTHCARE index has moved up from 29,042.6 to 42,622.8, registering a gain of 46.8% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 187.3%), SUVEN PHARMACEUTICALS (up 118.9%) and Glenmark Pharma (up 102.1%).

For Investors: Our Big Prediction

What About the Benchmark Indices?

The BSE Sensex is at 77,517.4 (down 0.2%).

The top losers among the BSE Sensex today are ITC (down 2.1%) and Hindustan Unilever (down 2.0%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 23,527.8 (down 0.1%). BPCL and ITC are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,259.5 to 77,517.4, registering a gain of 12,257.9 points (up 18.8%).

ASTRAZENECA PHARMA Financial Update...

ASTRAZENECA PHARMA net profit fell 121.9% YoY to Rs -118 million for the quarter ended June 2024, compared to a profit of Rs 539 million a year ago. Net sales rose 31.2% to Rs 3,875 million during the period as against Rs 2,955 million in April-June 2023.

For the year ended March 2024, ASTRAZENECA PHARMA reported 62.7% increase in net profit to Rs 1,615 million compared to net profit of Rs 993 million during FY23. Revenue of the company grew 29.2% to Rs 12,955 million during FY24.

The current Price to earnings ratio of ASTRAZENECA PHARMA, based on rolling 12 month earnings, stands at 176.2.


Equitymaster requests your view! Post a comment on "ASTRAZENECA PHARMA Plunges 5%; BSE HEALTHCARE Index Up 0.4%". Click here!